Skip to main content

18 September 2025

Last updated: Tuesday 16 September 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A new cell reprogramming approach for cancer

Saturday 26 October 2024

Interviewee/Contributor

Cristiana Pires

Organisation

Asgard Therapeutics AB

Organisations

MGB Biopharma Ltd
SFL Regulatory Affairs & Scientific Communication
US Food and Drug Administration
Swiss Federal Institute of Technology
MedNous contributing editor
Horizon Discovery Group Ltd
Bicycle Therapeutics Ltd
Parexel
SparingVision SAS
Max-Planck- Innovation GmbH

Interviewees and Contributers

Simon Ellison
Christian Jørgensen
Katherine Smith
Herve Brailly
Bruno Pagliara and Vittore Tamassia
Paul Higham
Justin Duckworth
Catherine Pickering
Max Hasmann
Friedrich von Bohlen

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form